JP3922800002
JP3922800002
MOCHIDA PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 116.951.000.000 | 105.159.000.000 | 11.2% |
| Cost of Revenue | 60.690.000.000 | 51.371.000.000 | 18.1% |
| Gross Profit | 56.260.000.000 | 53.787.000.000 | 4.6% |
| 46.113.000.000 | 45.661.000.000 | 1.0% | |
| Operating Income | 10.147.000.000 | 8.126.000.000 | 24.9% |
| Pretax Income | 11.171.000.000 | 8.052.000.000 | 38.7% |
| Net Income Common Stockholders | 7.903.000.000 | 5.685.000.000 | 39.0% |
| -- | -- | -- | |
| -- | -- | -- |